請選擇規(guī)格
¥18954
以上報價是含稅價格
規(guī)格
貨號:
規(guī)格
規(guī)格 | 50樣本、22樣本、8樣本、8樣本(產(chǎn)品加服務(wù))、50樣本(產(chǎn)品加服務(wù))、22樣本(產(chǎn)品加服務(wù)) |
樣本類型 | Cell Culture Supernatants, Plasma, Serum, Tissue Lysates, Other Body Fluids, Cell Lysates |
原理方法 | Sandwich-based |
檢測方法 | Fluorescence Laser Scanner |
定量與否 | Quantitative |
載體 | Glass Slide |
適用種屬 | Mouse |
檢測靶標 | CXCL16, MIP-2, LIX, MCP-5, MIP-1 gamma, Eotaxin-1 / CCL11, MIP-1 alpha / CCL3, RANTES / CCL5, BLC / CXCL13, MIG / CXCL9, CXCL2 / CINC-3 / MIP2, MCP-1 / CCL2, CXCL1 / GRO alpha / KC / CINC-1, MIP-3 alpha / CCL20, 6Ckine / CCL21, CTACK / CCL27, ENA-78 / CXCL5, Eotaxin-2 / MPIF-2 / CCL24, Fractalkine / CX3CL1, I-309 / TCA-3 / CCL1, I-TAC / CXCL11, MDC / CCL22, MIP-3 beta / CCL19, Platelet Factor 4 / CXCL4, SDF-1 alpha / CXCL12 alpha, TARC / CCL17, TECK / CCL25 |
靶標數(shù) | 25 |
詳細描述
Scroll over each target protein for more information | ||||
---|---|---|---|---|
6Ckine (CCL21)
| BLC (CXCL13)
| CTACK (CCL27)
| CXCL16
| Eotaxin-1 (CCL11)
|
Eotaxin-2 (MPIF-2/CCL24)
| Fractalkine (CX3CL1)
| I-309 (TCA-3/CCL1)
| I-TAC (CXCL11)
| KC (CXCL1)
|
LIX
| MCP-1 (CCL2)
| MCP-5
| MDC (CCL22)
| MIG (CXCL9)
|
MIP-1 alpha (CCL3)
| MIP-1 gamma
| MIP-2
| MIP-3 alpha (CCL20)
| MIP-3 beta (CCL19)
|
Platelet Factor 4 (CXCL4)
| RANTES (CCL5)
| SDF-1 alpha (CXCL12 alpha)
| TARC (CCL17)
| TECK (CCL25)
|
相關(guān)產(chǎn)品
Human Immune Checkpoint Receptor Protein Array
CHO Residual DNA Quantification Kit
Uric Acid Assay Kit (Colorimetric)
Total Cholesterol Assay Kit (Colorimetric)
Superoxide Dismutase (SOD) Activity Assay Kit (Colorimetric)
Peroxidase Activity Assay Kit (Colorimetric)
文件
文獻(1)
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy,Ni Jiali, Chen Chen, Wang Shuangan, Liu Xuan, Tan Liping, Lu Li, Fan Yu, Hou Yayi, Dou Huan, Liang Jun,ARTHRITIS RESEARCH & THERAPY ,(IF:4.9) 作者單位:南京鼓樓醫(yī)院 | |
Species: | Mouse |
Sample Type: | CT26 cell-Xenograft,serum |
通過郵件收到學(xué)術(shù)資源和優(yōu)惠信息
微信公眾號